Resilience is highly relevant in the context of cancer, and understanding how survivors adapt and potentially thrive following their diagnosis and treatment may provide insights into better supports and interventions to promote healthier survivorship. In this paper, we characterize two different ways to conceptualize and study resilience in cancer survivorship, as a trait and as a process.
Lab Alumni Spotlight
Graduate Student Presents at SBM 2021
Graduate student Kaleigh Ligus presented Social Connectedness, Pain, Emotion Regulation and Wellbeing in Older Adults in Active Treatment for Cancer at the Society for Behavioral Medicine (SBM) virtual conference on behalf of co-authors Tara Sanft, Crystal Park and Keith Bellizzi.
Book Chapter Commissioned: Transitions in Cancer Survivorship
A book chapter commissioned, “Resilience Trajectories of Cancer Survivors: A Meaning-Making Perspective”, within the textbook “Navigating Life Transitions for Meaning“, an Elsevier publication.
Sytematic Literature Review Published on HPV Vaccines in Boys
Dibble et al. (2019) published a systematic literature in the Journal of Adolescent and Young Adult Oncology (JAYAO) focusing on the importance of HPV vaccination in boys and young adult men, including its barriers from the perspective of boys/men, their parents, and their physicians.
Please click this link for an abstract.
NIH Grant UH3 Has Begun!
Drs. Bellizzi and Park received a multi-year grant (UH3) from the National Institutes of Health (NIH) in 2017. After completing a pilot phase with co-sponsors at Yale University, Dr. Tara Sanft, they began active recruitment in early 2019. Recruitment is scheduled to continue until sample saturation is met. For more information, please go to the study webpage, UConn-Yale Cancer Survivorship Study.
CTBHI Awards Dr. Bellizzi & PhD Student Grant to Study BRCA1/2
Dr. Bellizzi and doctoral student Kate Dibble, M.A. of UConn’s Department of Human Development and Family Sciences (HDFS) have received a one-year research grant to study the experiences of women testing positive for BRCA1/2 genetic mutations in undergoing genetic counseling within the United States. The study is a mixed methods, national sample and is one of the first of its kind in outlining the preferences of women testing positive for BRCA1/2 in undergoing individualized or family-based genetic counseling typologies.
New NIH Multi-Year Grant
Drs. Bellizzi and Park received a multi-year grant from the National Institutes of Health (NIH) to study the transition from active cancer treatment to survivorship. They plan to pilot this grant in a one-year phase in 2017, beginning the multi-year recruitment in 2019.